Glucagon Market Size, Share & COVID-19 Impact Analysis, By Route of Administration (Injectable and Inhalation), By Application (Hypoglycemia and Diagnostic Aid), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, and Online Pharmacies), and Regional Forecast, 2023-2030

Last Updated: December 01, 2025 | Format: PDF | Report ID: FBI108948

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

Schedule a 30 minutes session to understand our consulting capabilities – SCHEDULE NOW

Table of Content

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Prevalence of Hypoglycemia, Key Countries/Regions, 2022
2. Pipeline Analysis, By Key Players
3. Key Industry Developments, By Key Players
4. Impact of COVID-19 on the Market
Global Glucagon Market Analysis, Insights and Forecast, 2017-2030
1. Market Analysis, Insights and Forecast – By Route of Administration
  1. Injectable
  2. Inhalation
2. Market Analysis, Insights and Forecast – By Application
  1. Hypoglycemia
  2. Diagnostic Aid
3. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Drug Stores & Retail Pharmacies
  3. Online Pharmacies
4. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Glucagon Market Analysis, Insights and Forecast, 2017-2030
1. Market Analysis, Insights and Forecast – By Route of Administration
  1. Injectable
  2. Inhalation
2. Market Analysis, Insights and Forecast – By Application
  1. Hypoglycemia
  2. Diagnostic Aid
3. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Drug Stores & Retail Pharmacies
  3. Online Pharmacies
4. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe Glucagon Market Analysis, Insights and Forecast, 2017-2030
1. Market Analysis, Insights and Forecast – By Route of Administration
  1. Injectable
  2. Inhalation
2. Market Analysis, Insights and Forecast – By Application
  1. Hypoglycemia
  2. Diagnostic Aid
3. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Drug Stores & Retail Pharmacies
  3. Online Pharmacies
4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. U.K.
  2. Germany
  3. France
  4. Italy
  5. Spain
  6. Scandinavia
  7. Rest of Europe
Asia Pacific Glucagon Market Analysis, Insights and Forecast, 2017-2030
1. Market Analysis, Insights and Forecast – By Route of Administration
  1. Injectable
  2. Inhalation
2. Market Analysis, Insights and Forecast – By Application
  1. Hypoglycemia
  2. Diagnostic Aid
3. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Drug Stores & Retail Pharmacies
  3. Online Pharmacies
4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. Japan
  2. China
  3. India
  4. Australia
  5. Southeast Asia
  6. Rest of Asia Pacific
Latin America Glucagon Market Analysis, Insights and Forecast, 2017-2030
1. Market Analysis, Insights and Forecast – By Route of Administration
  1. Injectable
  2. Inhalation
2. Market Analysis, Insights and Forecast – By Application
  1. Hypoglycemia
  2. Diagnostic Aid
3. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Drug Stores & Retail Pharmacies
  3. Online Pharmacies
4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa Glucagon Market Analysis, Insights and Forecast, 2017-2030
1. Market Analysis, Insights and Forecast – By Route of Administration
  1. Injectable
  2. Inhalation
2. Market Analysis, Insights and Forecast – By Application
  1. Hypoglycemia
  2. Diagnostic Aid
3. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Drug Stores & Retail Pharmacies
  3. Online Pharmacies
4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. GCC
  2. South Africa
  3. Rest of Middle East & Africa
Competitive Analysis
1. Global Market Share Analysis (2022)
2. Company Profiles
  1. Novo Nordisk
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  2. Fresenius Kabi
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  3. Amphastar Pharmaceuticals, Inc.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  4. Xeris Biopharma Holdings, Inc.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  5. ILS.Inc
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  6. United Biotech Pvt. Ltd.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  7. Zealand Pharma A/S
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  8. Taj Pharmaceuticals Limited
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Prevalence of Hypoglycemia, Key Countries/Regions, 2022
2. Pipeline Analysis, By Key Players
3. Key Industry Developments, By Key Players
4. Impact of COVID-19 on the Market
Global Glucagon Market Analysis, Insights and Forecast, 2017-2030
1. Market Analysis, Insights and Forecast – By Route of Administration
  1. Injectable
  2. Inhalation
2. Market Analysis, Insights and Forecast – By Application
  1. Hypoglycemia
  2. Diagnostic Aid
3. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Drug Stores & Retail Pharmacies
  3. Online Pharmacies
4. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Glucagon Market Analysis, Insights and Forecast, 2017-2030
1. Market Analysis, Insights and Forecast – By Route of Administration
  1. Injectable
  2. Inhalation
2. Market Analysis, Insights and Forecast – By Application
  1. Hypoglycemia
  2. Diagnostic Aid
3. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Drug Stores & Retail Pharmacies
  3. Online Pharmacies
4. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe Glucagon Market Analysis, Insights and Forecast, 2017-2030
1. Market Analysis, Insights and Forecast – By Route of Administration
  1. Injectable
  2. Inhalation
2. Market Analysis, Insights and Forecast – By Application
  1. Hypoglycemia
  2. Diagnostic Aid
3. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Drug Stores & Retail Pharmacies
  3. Online Pharmacies
4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. U.K.
  2. Germany
  3. France
  4. Italy
  5. Spain
  6. Scandinavia
  7. Rest of Europe
Asia Pacific Glucagon Market Analysis, Insights and Forecast, 2017-2030
1. Market Analysis, Insights and Forecast – By Route of Administration
  1. Injectable
  2. Inhalation
2. Market Analysis, Insights and Forecast – By Application
  1. Hypoglycemia
  2. Diagnostic Aid
3. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Drug Stores & Retail Pharmacies
  3. Online Pharmacies
4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. Japan
  2. China
  3. India
  4. Australia
  5. Southeast Asia
  6. Rest of Asia Pacific
Latin America Glucagon Market Analysis, Insights and Forecast, 2017-2030
1. Market Analysis, Insights and Forecast – By Route of Administration
  1. Injectable
  2. Inhalation
2. Market Analysis, Insights and Forecast – By Application
  1. Hypoglycemia
  2. Diagnostic Aid
3. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Drug Stores & Retail Pharmacies
  3. Online Pharmacies
4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa Glucagon Market Analysis, Insights and Forecast, 2017-2030
1. Market Analysis, Insights and Forecast – By Route of Administration
  1. Injectable
  2. Inhalation
2. Market Analysis, Insights and Forecast – By Application
  1. Hypoglycemia
  2. Diagnostic Aid
3. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Drug Stores & Retail Pharmacies
  3. Online Pharmacies
4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. GCC
  2. South Africa
  3. Rest of Middle East & Africa
Competitive Analysis
1. Global Market Share Analysis (2022)
2. Company Profiles
  1. Novo Nordisk
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  2. Fresenius Kabi
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  3. Amphastar Pharmaceuticals, Inc.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  4. Xeris Biopharma Holdings, Inc.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  5. ILS.Inc
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  6. United Biotech Pvt. Ltd.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  7. Zealand Pharma A/S
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  8. Taj Pharmaceuticals Limited
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)

Read Less

List of Figures

Figure 01: Global Glucagon Market Revenue Breakdown (USD million, %) by Region, 2022 & 2030

Figure 02: Global Glucagon Market Value Share (%), by Route of Administration, 2022 & 2030

Figure 03: Global Glucagon Market Value (USD million), by Application, 2022 & 2030

Figure 04: Global Glucagon Market Value (USD million), by Distribution Channel, 2022 & 2030

Figure 05: Global Glucagon Market Value (USD million), by Region, 2022 & 2030

Figure 06: North America Glucagon Market Value (USD million), By Route of Administration, 2022 & 2030

Figure 07: North America Glucagon Market Value Share (%), By Route of Administration, 2022

Figure 08: North America Glucagon Market Value (USD million), by Application, 2022 & 2030

Figure 09: North America Glucagon Market Value Share (%), by Application, 2022

Figure 10: North America Glucagon Market Value (USD million), by Distribution Channel, 2022 & 2030

Figure 11: North America Glucagon Market Value Share (%), by Distribution Channel, 2022

Figure 12: North America Glucagon Market Value (USD million), By Country, 2022 & 2030

Figure 13: North America Glucagon Market Value Share (%), By Country, 2022

Figure 14: Europe Glucagon Market Value (USD million), By Route of Administration, 2022 & 2030

Figure 15: Europe Glucagon Market Value Share (%), By Route of Administration, 2022

Figure 16: Europe Glucagon Market Value (USD million), by Application, 2022 & 2030

Figure 17: Europe Glucagon Market Value Share (%), by Application, 2022

Figure 18: Europe Glucagon Market Value (USD million), by Distribution Channel, 2022 & 2030

Figure 19: Europe Glucagon Market Value Share (%), by Distribution Channel, 2022

Figure 20: Europe Glucagon Market Value (USD million), By Country/ Sub-region, 2022 & 2030

Figure 21: Europe Glucagon Market Value Share (%), By Country/ Sub-region, 2022

Figure 22: Asia Pacific Glucagon Market Value (USD million), By Route of Administration, 2022 & 2030

Figure 23: Asia Pacific Glucagon Market Value Share (%), By Route of Administration, 2022

Figure 24: Asia Pacific Glucagon Market Value (USD million), by Application, 2022 & 2030

Figure 25: Asia Pacific Glucagon Market Value Share (%), by Application, 2022

Figure 26: Asia Pacific Glucagon Market Value (USD million), by Distribution Channel, 2022 & 2030

Figure 27: Asia Pacific Glucagon Market Value Share (%), by Distribution Channel, 2022

Figure 28: Asia Pacific Glucagon Market Value (USD million), By Country/ Sub-region, 2022 & 2030

Figure 29: Asia Pacific Glucagon Market Value Share (%), By Country/ Sub-region, 2022

Figure 30: Latin America Glucagon Market Value (USD million), By Route of Administration, 2022 & 2030

Figure 31: Latin America Glucagon Market Value Share (%), By Route of Administration, 2022

Figure 32: Latin America Glucagon Market Value (USD million), by Application, 2022 & 2030

Figure 33: Latin America Glucagon Market Value Share (%), by Application, 2022

Figure 34: Latin America Glucagon Market Value (USD million), by Distribution Channel, 2022 & 2030

Figure 35: Latin America Glucagon Market Value Share (%), by Distribution Channel, 2022

Figure 36: Latin America Glucagon Market Value (USD million), By Country/ Sub-region, 2022 & 2030

Figure 37: Latin America Glucagon Market Value Share (%), By Country/ Sub-region, 2022

Figure 38: Middle East & Africa Glucagon Market Value (USD million), By Route of Administration, 2022 & 2030

Figure 39: Middle East & Africa Glucagon Market Value Share (%), By Route of Administration, 2022

Figure 40: Middle East & Africa Glucagon Market Value (USD million), by Application, 2022 & 2030

Figure 41: Middle East & Africa Glucagon Market Value Share (%), by Application, 2022

Figure 42: Middle East & Africa Glucagon Market Value (USD million), by Distribution Channel, 2022 & 2030

Figure 43: Middle East & Africa Glucagon Market Value Share (%), by Distribution Channel, 2022

Figure 44: Middle East & Africa Glucagon Market Value (USD million), By Country/ Sub-region, 2022 & 2030

Figure 45: Middle East & Africa Glucagon Market Value Share (%), By Country/ Sub-region, 2022

Figure 46: Global Glucagon Market Share (%), By Company, 2022

List of Tables

Table 01: Global Glucagon Market Revenue (USD million) Forecast, By Route of Administration, 2017–2030

Table 02: Global Glucagon Market Revenue (USD million) Forecast, By Application, 2017–2030

Table 03: Global Glucagon Market Revenue (USD million) Forecast, By Distribution Channel, 2017–2030

Table 04: Global Glucagon Market Revenue (USD million) Forecast, By Region, 2017-2030

Table 05: North America Glucagon Market Revenue (USD million) Forecast, By Route of Administration, 2017–2030

Table 06: North America Glucagon Market Revenue (USD million) Forecast, By Application, 2017–2030

Table 07: North America Glucagon Market Revenue (USD million) Forecast, By Distribution Channel, 2017–2030

Table 08: North America Glucagon Market Revenue (USD million) Forecast, By Country, 2017-2030

Table 09: Europe Glucagon Market Revenue (USD million) Forecast, By Route of Administration, 2017–2030

Table 10: Europe Glucagon Market Revenue (USD million) Forecast, By Application, 2017–2030

Table 11: Europe Glucagon Market Revenue (USD million) Forecast, By Distribution Channel, 2017–2030

Table 12: Europe Glucagon Market Revenue (USD million) Forecast, By Country/ Sub-region, 2017-2030

Table 13: Asia Pacific Glucagon Market Revenue (USD million) Forecast, By Route of Administration, 2017–2030

Table 14: Asia Pacific Glucagon Market Revenue (USD million) Forecast, By Application, 2017–2030

Table 15: Asia Pacific Glucagon Market Revenue (USD million) Forecast, By Distribution Channel, 2017–2030

Table 16: Asia Pacific Glucagon Market Revenue (USD million) Forecast, By Country/ Sub-region, 2017-2030

Table 17: Latin America Glucagon Market Revenue (USD million) Forecast, By Route of Administration, 2017–2030

Table 18: Latin America Glucagon Market Revenue (USD million) Forecast, By Application, 2017–2030

Table 19: Latin America Glucagon Market Revenue (USD million) Forecast, By Distribution Channel, 2017–2030

Table 20: Latin America Glucagon Market Revenue (USD million) Forecast, By Country/ Sub-region, 2017-2030

Table 21: Middle East & Africa Glucagon Market Revenue (USD million) Forecast, By Route of Administration, 2017–2030

Table 22: Middle East & Africa Glucagon Market Revenue (USD million) Forecast, By Application, 2017–2030

Table 23: Middle East & Africa Glucagon Market Revenue (USD million) Forecast, By Distribution Channel, 2017–2030

Table 24: Middle East & Africa Glucagon Market Revenue (USD million) Forecast, By Country/ Sub-region, 2017-2030

STUDY PERIOD: 2017-2030
BASE YEAR: 2022
HISTORICAL DATA: 2017-2021
NO OF PAGES: 133

Buy Now

Download Free Sample

Security Code

Growth Advisory Services

Clients

Related Reports

Biopharmaceuticals Market

Get In Touch With Us

US +1 833 909 2966 ( Toll Free )

UK +44 808 502 0280 ( Toll Free )

+91 744 740 1245 (APAC)
sales@fortunebusinessinsights.com